dm+d
441851004
Articles
Using lipid-lowering medicines while breastfeeding
25 September 2020
Medicine Compliance Aid Stability
CholestagelNeon Healthcare Ltd
Neon Healthcare Ltd
Cholestagel
Tablets f/c 625mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture.
9 November 2022
Lactation Safety Information
-
No published evidence of safety
Not absorbed from the mother’s GI tract
Theoretical effects of colestryramine on maternal cholesterol levels and availability of fat soluble vitamins (A, D, E, K) from the mother have not been shown to present a clinical risk to a breastfed infant
18 March 2017